
ELITE PHARMACEUTICALS INC /NV/
OTC · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
Elite Pharmaceuticals develops and manufactures generic prescription drugs, including controlled-release and abuse-deterrent formulations, primarily for pain management and other therapeutic categories. The company operates its own FDA-registered manufacturing facility in Northvale, New Jersey, supplying products to U.S. pharmaceutical distributors and partners.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Dash Barry HDirector | Buy | $26K | 100,000at $0.26 | Oct 9, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable ELTP activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.